Tan, A. C., Lai, G. G., Tan, G. S., Poon, S. Y., Doble, B., Lim, T. H., Aung, Z. W., Takano, A., Tan, W. L., Ang, M., Tan, B. S., Devanand, A., Too, C. W., Gogna, A., Ong, B., Koh, T. P., Kanesvaran, R., Ng, Q. S., Jain, A., Rajasekaran, T., Lim, A. S., Lim, W. T., Toh, C. K., Tan, E., Lim, T. K. H., & Tan, D. S. (2020). utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis. Lung cancer, 139, 207–215. http://access.bl.uk/ark:/81055/vdc_100098075084.0x00004e